More about

Meningococcal Disease

News
March 12, 2025
1 min read
Save

FDA approves Soliris for patients aged 6 years and up with generalized myasthenia gravis

The FDA has approved an expanded indication of Soliris, an IV-administered monoclonal antibody for patients aged 6 years and older with generalized myasthenia gravis who are anti-acetylcholine receptor antibody positive.

News
November 16, 2024
3 min watch
Save

VIDEO: ‘It’s an exciting time’ for meningococcal vaccination

NEW YORK — In this video at the Infectious Diseases in Children Symposium, Catherine Mary Healy, MBBCh, describes what she called “an exciting time” for meningococcal vaccines.

News
November 12, 2024
1 min read
Save

Top in ID: EDs not co-testing for HIV with STI screening; undetected bird flu infections

An analysis of STI screening for gonorrhea, chlamydia and syphilis at 11 EDs revealed that less than 3% of patients tested for one of the three STIs were also tested for HIV, despite the CDC’s recommendation for HIV co-testing.

News
November 04, 2024
2 min read
Save

FDA clears Qiagen panel for meningitis, encephalitis

The FDA on Monday cleared Qiagen’s 1-hour PCR test for meningitis and encephalitis, which the company said could help treat meningococcal disease more quickly.

News
October 25, 2024
2 min read
Save

ACIP votes to simplify meningococcal B vaccine recommendations

A CDC advisory committee on Thursday voted unanimously to “harmonize” serogroup B meningococcal vaccine recommendations for healthy adolescents and young adults and children who have a higher risk for infection.

News
April 09, 2024
2 min read
Save

Top in ID: US reports second case of H5N1 bird flu; FDA approves new antibiotic

A second person has tested positive for highly pathogenic avian influenza (H5N1), after being exposed to dairy cattle that were presumably infected with the virus.

News
April 04, 2024
4 min read
Save

Q&A: What to know about the increase in invasive meningococcal disease

The CDC alerted clinicians in the United States about a rise in invasive meningococcal disease caused by Neisseria meningitidis serogroup Y bacteria that could present with symptoms not typical of meningitis.

News
December 08, 2023
2 min read
Save

Party school ranking, campus Greek life increase meningococcal risk for college students

Researchers determined that first-year college students living on campus and/or affiliated with campus Greek life have an increased risk for meningococcal disease.

News
October 25, 2023
1 min read
Save

CDC committee recommends new pentavalent meningococcal vaccine

A CDC advisory committee voted 10-4 on Wednesday to recommend administering a newly approved pentavalent meningococcal vaccine when vaccination with both a MenACWY and MenB vaccine are indicated at the same visit.

News
October 20, 2023
1 min read
Save

FDA approves Penbraya for protection against meningococcal disease in young patients

Pfizer announced that the FDA has approved Penbraya, the first and only pentavalent vaccine for coverage against the most common serogroups causing meningococcal disease in people aged 10 to 25 years, according to a company press release.

View more